EUPRAXIA PHARMACEUTICALS INC. Form 40-F: Annual report of Canadian issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-03-13: Form 40-F; Period of report 2025-12-31; Description 40-F; Document d78249d40f.htm.
- 2025-03-20: Form 40-F; Period of report 2024-12-31; Description 40-F; Document d887586d40f.htm.
- 2024-04-01: Form 40-F; Period of report 2023-12-31; Description 40-F; Document d800041d40f.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-03-13 | 40-F | 2025-12-31 | 40-F | d78249d40f.htm |
| 2025-03-20 | 40-F | 2024-12-31 | 40-F | d887586d40f.htm |
| 2024-04-01 | 40-F | 2023-12-31 | 40-F | d800041d40f.htm |